November 2008 - Page 34 of 76

MondayNov 03, 2008 7:21 am

Iteris, Inc. (AMEX: ITI)

Iteris, Inc. (AMEX: ITI), a leader in the traffic management market, is focused on the development and application of advanced technologies that reduce traffic congestion, minimize the environmental impact of traffic congestion and improve the safety of surface transportation systems. By integrating outdoor image processing, traffic engineering and information technology, the company provides a wide array of Intelligent Transportation Systems and driver safety solutions to customers worldwide. For further information, visit the Company's web site at www.iteris.com.

MondayNov 03, 2008 7:20 am

INX Inc. (NASDAQ: INXI)

INX Inc. (NASDAQ: INXI) is a publicly traded network infrastructure professional services firm delivering best-of-class “Business Ready Solutions” to enterprise organizations. The company designs, implements, and supports the IP network infrastructure with a special emphasis on the Call Flow, Messaging, and Enablement layers. Inx Inc. is led by James H. Long who serves as the company’s CEO and Chairman of the Board. Long has a strong reputation in his field and an aggressive style that allows Inx to stay a step ahead of the competition. For further information, visit the company website at: www.inxi.com.

MondayNov 03, 2008 7:19 am

International Royalty Corporation (AMEX: ROY)

International Royalty Corporation (AMEX: ROY), a global mineral royalty company, has more than 85 royalties including an effective 2.7% NSR on the Voisey's Bay mine, a sliding scale NSR on the Chilean portion of the Pascua-Lama project, and a 1.5% NSR on approximately 3.0 million acres of gold lands in Western Australia. The company is led by CEO Douglas Silver who has 25 years of experience as an active professional in the minerals industries. For further information, visit the Company's web site at www.internationalroyalty.com.

MondayNov 03, 2008 7:19 am

International Montoro Resources Inc. (TSX: IMT CN)

International Montoro Resources Inc. (TSX: IMT CN), an emerging resource company, is focused on the acquisition, exploration and development of Uranium mineral properties in Saskatchewan, Ontario, British Columbia and Labrador as well as other resource properties in New Brunswick and Ontario. The company has been listed on the TSX Venture Exchange (formerly Vancouver Stock Exchange) for 18 years and has submitted its application to list on the Frankfurt Stock Exchange. For further information, visit the Company's web site at www.montororesources.com.

MondayNov 03, 2008 7:18 am

Inter-Atlantic Financial, Inc. (AMEX: IAN)

Inter-Atlantic Financial, Inc. (AMEX: IAN) is a newly organized blank check company formed for the purpose of acquiring, through a merger, a capital stock exchange, asset acquisition, stock purchase or other similar business combination, an unidentified domestic and/or foreign operating business in the financial services industry or businesses deriving a majority of their revenues from providing services to financial services companies, including for example, payment processing companies and technology providers. For further information, visit the company website at: www.interatlantic.com.

MondayNov 03, 2008 7:17 am

InterAmerican Acquisition Group Inc. (OTC BB: IAQG)

InterAmerican Acquisition Group Inc. (OTC BB: IAQG) is a blank check company recently formed for the purpose of acquiring, through a merger, stock exchange, asset acquisition or other similar business combination, an unidentified operating business. The company specializes in Project Management, Project Financing and Investment Banking. Recently, the company made news by raising $46 million. For further information, visit the company website at: www.interamerican-group.com.

MondayNov 03, 2008 7:16 am

Insmed Incorporated (NASDAQ: INSM)

Insmed Incorporated (NASDAQ: INSM), a development stage company, has comprehensive expertise in protein drug development. The company has a state-of-the art FDA-approved biologic commercial manufacturing facility in Boulder, Colorado and a corporate office in Richmond Virginia. By pursuing a dual path strategy, Insmed aims to advance its proprietary protein platform into niche markets with unmet needs while entering into the follow on biologics arena. For further information, visit the Company's web site at www.insmed.com.

MondayNov 03, 2008 7:08 am

InSite Vision Incorporated (AMEX: ISV)

InSite Vision Incorporated (AMEX: ISV) is focused on developing novel ophthalmic products for the treatment of a growing range of common eye problems, including ocular infection, glaucoma, and retinal disease. Their goal as a company is to provide patients and physicians with better treatment options that help preserve and improve vision worldwide. By leveraging their proprietary DuraSite® drug delivery technology, the company is creating alternative ocular anti-infective therapies that may provide substantial advantages over existing treatment options. For further information, visit the Company's web site at www.insite.com.

MondayNov 03, 2008 7:07 am

Inovio Biomedical Corporation (AMEX: INO)

Inovio Biomedical Corporation (AMEX: INO)Inovio Biomedical Corporation (AMEX: INO) has their focus on developing multiple DNA-based immunotherapies. The company is known as a leading developer of human applications of electroporation using brief, controlled electrical pulses to increase cellular uptake of a useful biopharmaceutical. Inovio's DNA delivery technology has demonstrated the ability to substantially increase gene expression and immune responses from DNA vaccines. For further information, visit the Company's web site at www.inovio.com.

MondayNov 03, 2008 7:07 am

Inhibitex, Inc. (NASDAQ: INHX)

Inhibitex, Inc. (NASDAQ: INHX) is a biopharmaceutical company engaging in the development of differentiated anti-infective products designed to prevent and treat serious infections. The company’s products include FV-100, a nucleoside analogue prodrug; HIV Integrase Inhibitors class of anti-retroviral agents; and a series of nucleoside and non-nucleoside HCV polymerase inhibitors designed to treat the hepatitis C virus. For further information, visit the Company's web site at www.inhibitex.com.

Site Search

Company Search

Month: November 2008